Medical News

Guest: Neeraj Agarwal, MD, FASCOGuest: Elena Castro, MD, PhD Guest: Neal Shore, MD, FACS Guest: Axel S. Merseburger, MD While the development of advanced prostate cancers is largely influenced by androgen receptor (AR) signaling, DNA-damage response (DDR) pathways also contribute to disease progression. AR axis-targeted therapies (ARATs) have been the standard of care for first-line mCRPC. Inhibiting PARP activity is an effective strategy for targeting malignant cells with

Host: Hector O. Chapa, MD, FACOG ACOG's Annual Clinical and Scientific Meeting will be held virtually this year, but that doesn't mean the content is any less collaborative and impactful. Listen in to hear what ReachMD's host and practicing OB-GYN, Dr. Hector Chapa, is looking forward to at this year's meeting.

Host: Linda Bernstein, Pharm.D. Asthma remains a significant global health problem, and more than 25 million Americans suffer from it. How have the National Asthma Education and Prevention Program’s guidelines changed to help manage this chronic condition? In this episode of The Drug Report, Dr. Linda Bernstein reviews new guidelines on the management of asthma in adolescents and adults. Published December 10, 2020

Host: Matt Birnholz, MD After the American College of Surgeons and the Surgeon General's suspension of non-emergent surgeries and procedures, Dr. Matt Birnholz explains the new guidelines and their impact on patients. Published April 2, 2020

[Read the Article] The U.S. Preventative Services Task Force has updated the recommendations regarding colorectal cancer screening. The Task Force strongly recommends screening average risk adults age 50 to 75 for colorectal cancer, and then making individual screening decisions for adults age 76 to 85, taking into account the patient's overall health and screening history.Colorectal cancer is the second leading cause of cancer death in the United States, and about one-third of adults in